Drug intelligence / Profile preview

EcoShield PX

Development stage: Unknown
Lead developer: Intralytix
Modality: Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Topical

Overview

EcoShield PX is a bacteriophage-based food safety biologic developed by Intralytix, Inc. It consists of a cocktail of naturally occurring lytic bacteriophages that specifically target and kill Shiga toxin-producing Escherichia coli (STEC), including E. coli O157:H7 and the 'big six' serogroups (O26, O45, O103, O111, O121, and O145). The product is applied topically as a spray or wash to various food surfaces, such as red meat, poultry, dairy, and produce, to eliminate or significantly reduce bacterial contamination and prevent foodborne illness. EcoShield PX has received FDA Generally Recognized as Safe (GRAS) status (GRN 000834) and Food Contact Notification (FCN No. 1018) for use as a processing aid in food production.

Brand names: EcoShield PX
Other names: EcoShield

Beyond the preview

Go deeper on EcoShield PX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EcoShield PX.

Explore the full profile